Real‐world tolerance and outcomes of oxaliplatin‐based adjuvant chemotherapy for stage III colon cancer—Does dose intensity matter?

Robert Yoon, Weng Ng, Gabriel Gabriel et al.|Asia-Pacific Journal of Clinical Oncology|2023

Cited by 4